Skip to content
value.today

Medicom Technologies, Inc.

Total raised
$42 M
6 rounds on record
Latest round
$9 M
Mar 2024
First round on record
Jul 2017
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Medicom Technologies, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2024$9 MNo. 6$2 to $10 million

Medicom Technologies, Inc.: Raise no. 6, Mar 2024

Investors in this round

11 investors had bought by the notice of Jul 17, 2024: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $9 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Malcolm Benitz · Executive Officer, Director
  • Michael Rosenberg · Executive Officer, Director, Promoter
  • JT Vaughn · Director
  • Justin Wright-Eakes · Director
  • Michael Seiden · Director
  • Mike Becker · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for working capital, which may include normal compensation to executive officers.”

Signed by Michael Rosenberg, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Jul 17, 2024. Read the notice at the SEC.

debt, optionsSEC
Nov 2021$22 MNo. 5$10 to $50 million

Medicom Technologies, Inc.: Raise no. 5, Nov 2021

Investors in this round

16 investors had bought by the notice of Nov 18, 2021: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$22 M of $22 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,030,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chase Ballard · Executive Officer
  • Chris Woodlief · Executive Officer
  • Malcolm Benitz · Executive Officer, Director
  • Michael Rosenberg · Executive Officer, Director, Promoter
  • JT Vaughn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Bentley Securities Corporation (CRD 25759) · New York, New YorkSold in AL, AZ, CA, CO, CT, DC, FL, GA, IA, IL, MA, MD, MI, MN, NC, NJ, NY, PA, SC, TN, TX, UT, VA, WA, WI

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for working capital, which may include normal compensation to executive officers.”

Signed by Michael Rosenberg, Ceo. Source: SEC Form D, newest notice filed Nov 18, 2021. Read the notice at the SEC.

equitySEC
Aug 2021$1 MNo. 4Under $2 million

Medicom Technologies, Inc.: Raise no. 4, Aug 2021

Investors in this round

1 investor had bought by the notice of Sep 8, 2021: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $2 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chase Ballard · Executive Officer
  • Chris Woodlief · Executive Officer
  • Malcolm Benitz · Executive Officer, Director, Promoter
  • Michael Rosenberg · Executive Officer, Director
  • JT Vaughn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for working capital, which may include normal compensation to executive officers.”

Signed by Malcolm Benitz, Coo. Source: SEC Form D, newest notice filed Sep 8, 2021. Read the notice at the SEC.

debt, optionsSEC
Aug 2020$3 MNo. 3$2 to $10 million

Medicom Technologies, Inc.: Raise no. 3, Aug 2020

Investors in this round

7 investors had bought by the notice of Jan 22, 2021: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chase Ballard · Executive Officer
  • Chris Woodlief · Executive Officer
  • Malcolm Benitz · Executive Officer, Director, Promoter
  • Michael Rosenberg · Executive Officer, Director
  • JT Vaughn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for working capital, which may include normal compensation to executive officers.”

Signed by Malcolm Benitz, Coo. Source: SEC Form D and 1 amendment, newest notice filed Jan 22, 2021. Read the notice at the SEC.

debt, optionsSEC
Dec 2019$1 MNo. 2Under $2 million

Medicom Technologies, Inc.: Raise no. 2, Dec 2019

Investors in this round

2 investors had bought by the notice of Feb 20, 2020: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chase Ballard · Executive Officer
  • Chris Woodlief · Executive Officer
  • Malcolm Benitz · Executive Officer, Director, Promoter
  • Michael Rosenberg · Executive Officer, Director
  • JT Vaughn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for working capital, which may include normal compensation to executive officers.”

Signed by Malcolm Benitz, Ceo. Source: SEC Form D, newest notice filed Feb 20, 2020. Read the notice at the SEC.

debt, optionsSEC
Jul 2017$5 MNo. 1$2 to $10 million

Medicom Technologies, Inc.: Raise no. 1, Jul 2017

Investors in this round

11 investors had bought by the notice of Aug 4, 2017: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chase Ballard · Executive Officer
  • Chris Woodlief · Executive Officer
  • Malcolm Benitz · Executive Officer, Director, Promoter
  • Michael Rosenberg · Executive Officer, Director
  • JT Vaughn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for working capital, which may include normal compensation to executive officers.”

Signed by Malcolm Benitz, Ceo. Source: SEC Form D, newest notice filed Aug 4, 2017. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Medicom Technologies, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2024).

    SEC Form D · Jul 2024

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Jul 2024

That is all the official record says: Medicom Technologies, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Medicom Technologies, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 16 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Medicom Technologies, Inc.
NameRoleNamed in
Malcolm BenitzExecutive officerJul 2024
Michael RosenbergExecutive officerJul 2024
Chase BallardExecutive officerNov 2021
Chris WoodliefExecutive officerNov 2021
JT VaughnDirectorJul 2024
Justin Wright-EakesDirectorJul 2024
Malcolm BenitzDirectorJul 2024
Michael RosenbergDirectorJul 2024
Michael SeidenDirectorJul 2024
Mike BeckerDirectorJul 2024
Michael RosenbergPromoterJul 2024
Malcolm BenitzPromoterSep 2021